Anuh Pharma (Small Cap - Potential Multibagger) Share Target 2025, 2026 To 2035
|
Anuh Pharma Limited |
|||
|
Price: ₹207.10 (+3.16%) | ||
| 52 Week Low: ₹155.10 52 Week High: ₹265.00 |
|||
| Market Capital: 949.37 Crore (Smallcap) | |||
| -> | |||
Show Table of Contents
Table of Contents
- 1: Approach 1: Technical Analysis Paired With Price Action
- 1.1: Anuh Pharma Share Price Target For 2025
- 1.1.1: Anuh Pharma Share Price Target Table For 2025
- 1.1.2: Short-Term Technical Outlook
- 1.2: Anuh Pharma Share Price Target For 2026
- 1.2.1: Anuh Pharma Share Price Target Table For 2026
- 1.2.2: Long-Term Technical Outlook
- 2: Approach 2: Machine Learning By Studying Historical Prices
- 2.1: Anuh Pharma Share Price Target Chart and Table From 2025, 2026, 2027 to 2035
- 3: Anuh Pharma Financial Performance
- 3.0.1: Is Anuh Pharma A Good Buy For Long Term?
Anuh Pharma, a Small Cap company has delivered 218.1% returns in 5-year showing 20.3% quarterly revenue growth with 24.8% profit margin, making it a potential Multibagger.
To predict the Anuh Pharma's future market prices, we harnessed 2 dynamic approaches:
Approach 1: Technical Analysis Paired With Price Action
Approach 2: Machine Learning By Studying Historical Prices
Approach 1: Technical Analysis Paired With Price Action
Anuh Pharma Share Price Target For 2025
The line chart displays the monthly closing prices of Anuh Pharma with a black line. The green line shows three potential target prices for 2025, while the red line indicates three potential Stop Loss levels.
For detailed target and stop loss values for Anuh Pharma shares in 2025, see the table below.
Anuh Pharma Share Price Target Table For 2025
| Level | Value | Analysis |
|---|---|---|
| 2025 Target 3 | 223.9 (+8.11%) | Price Action: 24 Dec 2024 High |
| 2025 Target 2 | 221.64 (+7.02%) | Price Action: 16 Jul 2024 Low |
| 2025 Target 1 | 219.27 (+5.87%) | Price Action: 04 Jun 2024 High |
| Current Price | 207.10 | Anuh Pharma's share price as of 23 Jan 2025 |
| Stop Loss 1 | 201.65 (-2.64%) | Price Action: 26 Nov 2024 High |
| Stop Loss 2 | 199.61 (-3.62%) | Price Action: Jun 2024 Low |
| Stop Loss 3 | 197.29 (-4.74%) | Price Action: 14 Mar 2024 Low |
Short-Term Technical Outlook
Current Technical Position: Anuh Pharma is displaying bearish momentum trading below key moving averages.
Key Technical Level: The 50-day moving average at ₹211.91 serves as the nearest technical reference point.
Historical Returns: 3-month: +7.86% | 6-month: -13.03% | 1-year: +26.28%
Anuh Pharma Share Price Target For 2026
The line chart displays the monthly closing prices of Anuh Pharma with a black line. The green line shows three potential target prices for 2026, while the red line indicates three potential Stop Loss levels.
For detailed target and stop loss values for Anuh Pharma shares in 2026, see the table below.
Anuh Pharma Share Price Target Table For 2026
| Level | Value | Analysis |
|---|---|---|
| 2026 Target 3 | 337.97 (+63.19%) | Price Action: Chart |
| 2026 Target 2 | 331.67 (+60.14%) | Price Action: Chart |
| 2026 Target 1 | 328.39 (+58.56%) | Fibonacci Extension Level 64.90% |
| Current Price | 207.10 | Anuh Pharma's share price as of 23 Jan 2025 |
| Stop Loss 1 | 177.53 (-14.28%) | Price Action: 04 Jan 2024 High |
| Stop Loss 2 | 175.55 (-15.24%) | Price Action: 05 Feb 2024 High |
| Stop Loss 3 | 172.89 (-16.52%) | Price Action: 05 Jan 2024 Low |
Long-Term Technical Outlook
52-Week Range Analysis: Anuh Pharma is currently trading at 47.3% of its 52-week range (₹155.1 - ₹265).
Long-Term Trend Analysis: The stock is in a bearish long-term trend, trading below key long-term moving averages.
Long-Term Performance: 1-year: +26.28% | 3-year: +101.85% | 5-year: +218.08%
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
Approach 2: Machine Learning By Studying Historical Prices
Anuh Pharma Share Price Target Chart and Table From 2025, 2026, 2027 to 2035
| Year | Target 1 | Target 1 YoY Chg % | Target 2 |
|---|---|---|---|
| Current Price | ₹207.10 | ||
| 2025 | ₹302.02 | +45.83% | ₹306.55 |
| 2026 | ₹389.96 | +29.11% | ₹395.81 |
| 2027 | ₹570.37 | +46.26% | ₹578.93 |
| 2028 | ₹749.01 | +31.32% | ₹760.25 |
| 2029 | ₹979.94 | +30.83% | ₹994.64 |
| 2030 | ₹1,224.40 | +24.94% | ₹1,242.77 |
| 2031 | ₹1,620.18 | +32.32% | ₹1,644.48 |
| 2032 | ₹2,166.54 | +33.72% | ₹2,199.04 |
| 2033 | ₹2,581.91 | +19.17% | ₹2,620.64 |
| 2034 | ₹3,146.43 | +21.86% | ₹3,193.63 |
| 2035 | ₹3,773.21 | +19.92% | ₹3,829.81 |
Note: Target 1 and Target 2 represent price levels that the stock is most likely to achieve during the respective year, based on machine learning algorithms analyzing historical price patterns and market behavior. These predictions are generated through comprehensive analysis of the stock's historical data using advanced ML models.
Anuh Pharma Financial Performance
| Metric | Value | Description |
|---|---|---|
| Market Capital | 949.37 Crore | Market valuation of Anuh Pharma's shares. |
| Revenue (TTM) | 647 Crore | Total revenue generated by Anuh Pharma over the past twelve months. |
| Net Income (TTM) | +60.05 Crore | Net Profit or Loss after all the expenses over the past twelve months. |
| Operating Margin | +12.15% | Income from operations as a percentage of revenue, before taxes and interest. |
| Profit Margin | +24.78% | Net income as a percentage of revenue, after all expenses. |
| Revenue Growth (Quarterly) |
+20.32% | Change in revenue compared to the previous quarter. |
| Debt-to-Equity (D/E) Ratio |
0.04 | Company's total debt divided by total shareholder equity. |
| Total Debt | 14.1 Crore | Sum of Anuh Pharma's current & long-term financial obligations. |
Is Anuh Pharma A Good Buy For Long Term?
Anuh Pharma, a small-cap stock with a market capitalization of ₹949.37 crore, shows mixed signals. While its ₹60.05 crore net profit (24.78% margin) on ₹647 crore revenue (TTM) is positive, a significant revenue increase of 20.33% QoQ needs further investigation. Despite strong 12-month (50.96%) and YTD (32.93%) returns, recent performance has been weak (-19.15% over 3 months, -21.45% over 6 months). The low debt of ₹14.1 crore is a plus. Given the volatility, Anuh Pharma is an average buy for the long term; further due diligence is recommended before investment.
Disclaimer: The information provided on this page is for educational purposes only and should not be considered as financial advice. Historical performance data and technical analysis cannot guarantee future results. Stock investments are subject to market risks. Please consult with a qualified financial advisor before making any investment decisions.
All stock data shown is sourced from publicly available information and while we strive for accuracy, we cannot guarantee the absolute accuracy of all figures. Users should verify critical information from official sources before making investment decisions.
